Walleye Trading
BEAM icon

Walleye Trading’s Beam Therapeutics BEAM Stock Holding History

Walleye Trading’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,500
Closed -$203K – 3982
2026
Q1 		$203K Sell
8,500
-10,000
-54% -$277K ﹤0.01% 3113
2025
Q4 		$513K Buy
18,500
+2,500
+16% +$63.8K ﹤0.01% 2808
2025
Q3 		$388K Buy
16,000
+11,400
+248% +$227K ﹤0.01% 2916
2025
Q2 		$78.2K Buy
+4,600
New +$80.1K ﹤0.01% 3689
2024
Q1 		– Sell
-30,700
Closed -$836K – 4763
2023
Q4 		$836K Buy
30,700
+17,400
+131% +$432K ﹤0.01% 2637
2023
Q3 		$320K Sell
13,300
-44,900
-77% -$1.2M ﹤0.01% 3317
2023
Q2 		$1.86M Buy
58,200
+29,600
+103% +$961K 0.01% 1708
2023
Q1 		$876K Buy
28,600
+4,600
+19% +$182K ﹤0.01% 2316
2022
Q4 		$939K Sell
24,000
-42,300
-64% -$1.89M ﹤0.01% 2270
2022
Q3 		$3.16M Buy
66,300
+56,300
+563% +$3.21M 0.01% 1349
2022
Q2 		$387K Buy
10,000
+5,700
+133% +$227K ﹤0.01% 3150
2022
Q1 		$246K Buy
+4,300
New +$282K ﹤0.01% 3625

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Walleye Trading's BEAM Position: Q2 2026 in Review

Walleye Trading sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 183 shares — an estimated $4.36K sold.

Walleye Trading first reported a position in BEAM in Q2 2022 and held it in 6 quarters. The position peaked at $508K in Q4 2022. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Walleye Trading reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 183 Beam Therapeutics shares in Q2 2026, an estimated $4.36K.
  • Walleye Trading first reported a position in Beam Therapeutics in Q2 2022 and held it in 6 quarters.
  • Walleye Trading's Beam Therapeutics position peaked at $508K in Q4 2022.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.